Does this patient retention model actually align with clinical timelines?
Hey stem cell doctors,so I want to build operational systems for clinics and I’m looking for feedback on a retention architecture I'm mapping out. I have zero interest in pitching anyone here; I just want your clinical perspective so I don't build something useless.
Most marketers push cold Facebook ads, which seems terrible for high-ticket biologics. My thing is that clinics lose massive revenue simply because past PRP/Stem cell patients naturally wear off after 12-18 months and quietly go to an orthopedic surgeon instead of coming back for a booster.
I'm building an automated backend that syncs with the EMR to track those timelines without the front desk lifting a finger:
• The 6-Month Loop: Automatically texts past biologic patients offering a low-cost complementary service (like a Red Light session). The goal is to assess their pain levels while cellular healing is peaking, ensure they are happy, and secure a Google review.
• The 12-Month Booster Loop: Reaches out at 12 (and 18) months offering a premium value-add (like a complimentary Shockwave session). The goal is to get them back in the chair for a joint evaluation right as the original treatment might be wearing off, making it easy to recommend a biologic booster.
The system uses AI intent filtering so the front desk only gets notified to call if the patient specifically texts back "YES".
My questions for the actual practitioners:
- Do these 6 and 12-month marks align with the biological reality of when your patients actually need follow-ups or boosters?
- Would this solve a genuine bottleneck for your front desk, or does this sound like overkill?
Appreciate any honest feedback!